Journal article

Projected Burden of Osteoarthritis and Rheumatoid Arthritis in Australia: A Population-Level Analysis

Ilana N Ackerman, Clare Pratt, Alexandra Gorelik, Danny Liew

Arthritis Care & Research | WILEY | Published : 2017

Abstract

Objective To forecast the prevalence and direct health care costs of osteoarthritis (OA) and rheumatoid arthritis (RA) in Australia to the year 2030. Methods An epidemiologic model of the Australian population was developed. Data on the national prevalence of OA and RA were obtained from the Australian Bureau of Statistics (ABS) 2014–2015 National Health Survey. Future prevalence was estimated using ABS population projections for 2020, 2025, and 2030. Available government data on direct health care expenditure for OA and RA were modeled to forecast costs (in Australian $) for the years 2020, 2025, and 2030, from the perspective of the Australian public health care system. Results The n..

View full abstract

Grants

Awarded by National Health and Medical Research Council of Australia Public Health Early Career Fellowship


Funding Acknowledgements

Supported by Arthritis Australia through the Medicines Australia Community Chest. Medicines Australia Community Chest receives support from AbbVie Pty, AstraZeneca Pty, Eli Lilly Australia Pty, Janssen-Cilag Pty, Pfizer Australia Pty, and Roche Products Pty. Dr. Ackerman's work was supported by a National Health and Medical Research Council of Australia Public Health Early Career Fellowship (#520004).